Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
The presentations cover topics including: Update from TGA to Sector (A01c) Manufacturing Quality and GMP Clearance (A02) In vitro diagnostic (IVD) medical device - reforms and processes (A05) Finding the way to the ARTG for medical devices (A11) Section 19A vs Section 14/14A: a practical approach to reducing the impact of medicine shortages (A16) Software and AI compliance and reforms (A17) Clinical Trials and Good Clinical Practice (GCP) (B02) Labelling TGO 92 update - non-prescription medicines (B09) Labelling TGO 91 update - prescription medicines (B22) Update from TGAs Pharmacovigilance Branch (B13) Prescription Medicine Authorisation Branch update - Q&A panel session (B16) Real World Evidence (C08) A sincere thank you to the TGA presenters for sharing their expertise at the conference and for making these resources available to the wider community
Choosing between oral and injectable tirzepatide is not just a preference question about needles versus drops
TA1 / Thymosin Alpha 1 Support FAQs 01What is TA1 / Thymosin Alpha 1 used for
The true cost of a low-quality peptide isn't its sticker price
US$ 23.48
US$ 24.86
US$ 28.86
US$ 25.15
US$ 21.00
